HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eike Burandt Selected Research

cytochrome C oxidase subunit II

10/2021High mitochondrial content is associated with breast cancer aggressiveness.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eike Burandt Research Topics

Disease

59Neoplasms (Cancer)
08/2022 - 03/2010
21Prostatic Neoplasms (Prostate Cancer)
06/2021 - 05/2018
9Breast Neoplasms (Breast Cancer)
02/2022 - 12/2013
9Carcinoma (Carcinomatosis)
01/2022 - 01/2019
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2022 - 10/2013
6Neoplasm Metastasis (Metastasis)
01/2022 - 01/2016
6Microsatellite Instability
01/2022 - 01/2020
5Adenocarcinoma
02/2022 - 10/2013
5Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 03/2012
5Lymphatic Metastasis
06/2021 - 10/2018
5Vulvar Neoplasms (Vulvar Cancer)
03/2021 - 01/2016
4Colorectal Neoplasms (Colorectal Cancer)
02/2022 - 03/2014
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 10/2020
4Genomic Instability
01/2021 - 01/2020
2Acinar Cell Carcinoma
01/2022 - 01/2022
2Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
11/2021 - 06/2021
2Anaplastic Thyroid Carcinoma
10/2021 - 06/2021
2Seminoma
03/2021 - 08/2019
2Turcot syndrome
03/2021 - 01/2020
27 Hereditary Prostate Cancer
07/2020 - 10/2019
2Hodgkin Disease (Hodgkin's Disease)
06/2020 - 12/2018
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 11/2014
2Margins of Excision
10/2019 - 10/2018
2Small Cell Carcinoma
09/2019 - 01/2019
1Mesothelioma
02/2022
1Stomach Neoplasms (Stomach Cancer)
01/2022
1Pheochromocytoma
01/2022
1Triple Negative Breast Neoplasms
01/2022
1Pancreatitis
01/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Colonic Neoplasms (Colon Cancer)
01/2022
1Adrenocortical Adenoma (Disease, Conn's)
01/2022
1Teratoma (Teratoid Tumor)
12/2021
1Pleomorphic Adenoma
12/2021
1Papillomavirus Infections
12/2021
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2021
1Thyroid Neoplasms (Thyroid Cancer)
10/2021
1Unknown Primary Neoplasms
10/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2021
1Chondrosarcoma
10/2021
1Lobular Carcinoma
06/2021
1Merkel Cell Carcinoma
06/2021
1Squamous Cell Neoplasms (Squamous Cell Cancer)
03/2021
1Smooth Muscle Tumor
11/2020
1Leiomyosarcoma
11/2020

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
08/2022 - 03/2012
11Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2019
9Immune Checkpoint InhibitorsIBA
09/2021 - 08/2019
7AntibodiesIBA
02/2022 - 03/2010
4Estrogen ReceptorsIBA
02/2022 - 12/2019
4Progesterone Receptors (Progesterone Receptor)IBA
02/2022 - 10/2016
3Prostate-Specific Antigen (Semenogelase)IBA
01/2021 - 10/2018
2Mucin 5ACIBA
01/2022 - 08/2021
2MucinsIBA
01/2022 - 08/2021
2MesothelinIBA
10/2021 - 04/2021
2Cadherins (E-Cadherin)IBA
06/2021 - 01/2016
2Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2020
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2020 - 10/2019
2Androgen Receptors (Androgen Receptor)IBA
07/2019 - 01/2019
2Formaldehyde (Formol)FDA Link
12/2018 - 10/2013
2SteroidsIBA
08/2014 - 02/2014
2Trastuzumab (Herceptin)FDA Link
03/2014 - 12/2013
1Keratin-20 (Cytokeratin 20)IBA
01/2022
1sacituzumab govitecanIBA
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1Keratin-7 (Cytokeratin 7)IBA
01/2022
1Carboxypeptidases A (Carboxypeptidase A)IBA
01/2022
1AS 8IBA
01/2022
1Surface Antigens (Surface Antigen)IBA
01/2022
1ArginaseIBA
12/2021
1Bicarbonates (Hydrogen Carbonate)IBA
12/2021
1CalciumIBA
12/2021
1ChloridesIBA
12/2021
1placental alkaline phosphataseIBA
11/2021
1ThyroglobulinFDA Link
10/2021
1Glycoproteins (Glycoprotein)IBA
10/2021
1cytochrome C oxidase subunit IIIBA
10/2021
1Colloids (Colloid)IBA
10/2021
1EpitopesIBA
10/2021
1pembrolizumabIBA
03/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2021
1Bevacizumab (Avastin)FDA Link
03/2021
1Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2021
1Mismatch Repair Endonuclease PMS2IBA
03/2021
1PENTAIBA
03/2021
1Keratins (Keratin)IBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Keratin-19 (Keratin 19)IBA
01/2021
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2021
1Keratin-18 (Keratin 18)IBA
01/2021
1transgelinIBA
11/2020
1WD repeat containing planar cell polarity effectorIBA
10/2020
1Claudin-1IBA
09/2020

Therapy/Procedure

13Therapeutics
12/2021 - 03/2014
3Radiotherapy
03/2021 - 10/2016
3Lasers (Laser)
11/2014 - 10/2013
2Immunotherapy
03/2021 - 12/2018
2Prostatectomy (Retropubic Prostatectomy)
01/2019 - 01/2019
2Lymph Node Excision (Lymph Node Dissection)
01/2019 - 01/2016
2Drug Therapy (Chemotherapy)
10/2017 - 01/2016